244 related articles for article (PubMed ID: 18046660)
1. Chromogranin a expression in phaeochromocytomas associated with von Hippel-Lindau syndrome and multiple endocrine neoplasia type 2.
Cleary S; Phillips JK; Huynh TT; Pacak K; Fliedner S; Elkahloun AG; Munson P; Worrell RA; Eisenhofer G
Horm Metab Res; 2007 Dec; 39(12):876-83. PubMed ID: 18046660
[TBL] [Abstract][Full Text] [Related]
2. Different expression of catecholamine transporters in phaeochromocytomas from patients with von Hippel-Lindau syndrome and multiple endocrine neoplasia type 2.
Huynh TT; Pacak K; Brouwers FM; Abu-Asab MS; Worrell RA; Walther MM; Elkahloun AG; Goldstein DS; Cleary S; Eisenhofer G
Eur J Endocrinol; 2005 Oct; 153(4):551-63. PubMed ID: 16189177
[TBL] [Abstract][Full Text] [Related]
3. Pheochromocytomas in von Hippel-Lindau syndrome and multiple endocrine neoplasia type 2 display distinct biochemical and clinical phenotypes.
Eisenhofer G; Walther MM; Huynh TT; Li ST; Bornstein SR; Vortmeyer A; Mannelli M; Goldstein DS; Linehan WM; Lenders JW; Pacak K
J Clin Endocrinol Metab; 2001 May; 86(5):1999-2008. PubMed ID: 11344198
[TBL] [Abstract][Full Text] [Related]
4. Differential expression of erythropoietin and its receptor in von hippel-lindau-associated and multiple endocrine neoplasia type 2-associated pheochromocytomas.
Vogel TW; Brouwers FM; Lubensky IA; Vortmeyer AO; Weil RJ; Walther MM; Oldfield EH; Linehan WM; Pacak K; Zhuang Z
J Clin Endocrinol Metab; 2005 Jun; 90(6):3747-51. PubMed ID: 15769989
[TBL] [Abstract][Full Text] [Related]
5. Proteomic profiling of von Hippel-Lindau syndrome and multiple endocrine neoplasia type 2 pheochromocytomas reveals different expression of chromogranin B.
Brouwers FM; Gläsker S; Nave AF; Vortmeyer AO; Lubensky I; Huang S; Abu-Asab MS; Eisenhofer G; Weil RJ; Park DM; Linehan WM; Pacak K; Zhuang Z
Endocr Relat Cancer; 2007 Jun; 14(2):463-71. PubMed ID: 17639059
[TBL] [Abstract][Full Text] [Related]
6. Neuropeptide Y expression in phaeochromocytomas: relative absence in tumours from patients with von Hippel-Lindau syndrome.
Cleary S; Phillips JK; Huynh TT; Pacak K; Elkahloun AG; Barb J; Worrell RA; Goldstein DS; Eisenhofer G
J Endocrinol; 2007 May; 193(2):225-33. PubMed ID: 17470513
[TBL] [Abstract][Full Text] [Related]
7. Transcriptional regulation of phenylethanolamine N-methyltransferase in pheochromocytomas from patients with von Hippel-Lindau syndrome and multiple endocrine neoplasia type 2.
Huynh TT; Pacak K; Wong DL; Linehan WM; Goldstein DS; Elkahloun AG; Munson PJ; Eisenhofer G
Ann N Y Acad Sci; 2006 Aug; 1073():241-52. PubMed ID: 17102092
[TBL] [Abstract][Full Text] [Related]
8. Pheochromocytoma in von hippel-lindau disease: distinct histopathologic phenotype compared to pheochromocytoma in multiple endocrine neoplasia type 2.
Koch CA; Mauro D; Walther MM; Linehan WM; Vortmeyer AO; Jaffe R; Pacak K; Chrousos GP; Zhuang Z; Lubensky IA
Endocr Pathol; 2002; 13(1):17-27. PubMed ID: 12114747
[TBL] [Abstract][Full Text] [Related]
9. Pheochromocytomas, multiple endocrine neoplasia type 2, and von Hippel-Lindau disease.
Neumann HP; Berger DP; Sigmund G; Blum U; Schmidt D; Parmer RJ; Volk B; Kirste G
N Engl J Med; 1993 Nov; 329(21):1531-8. PubMed ID: 8105382
[TBL] [Abstract][Full Text] [Related]
10. Contrasting clinical manifestations of SDHB and VHL associated chromaffin tumours.
Srirangalingam U; Khoo B; Walker L; MacDonald F; Skelly RH; George E; Spooner D; Johnston LB; Monson JP; Grossman AB; Drake WM; Akker SA; Pollard PJ; Plowman N; Avril N; Berney DM; Burrin JM; Reznek RH; Kumar VK; Maher ER; Chew SL
Endocr Relat Cancer; 2009 Jun; 16(2):515-25. PubMed ID: 19208735
[TBL] [Abstract][Full Text] [Related]
11. Plasma normetanephrine and metanephrine for detecting pheochromocytoma in von Hippel-Lindau disease and multiple endocrine neoplasia type 2.
Eisenhofer G; Lenders JW; Linehan WM; Walther MM; Goldstein DS; Keiser HR
N Engl J Med; 1999 Jun; 340(24):1872-9. PubMed ID: 10369850
[TBL] [Abstract][Full Text] [Related]
12. Phaeochromocytoma associated with a de novo VHL mutation as form fruste of von Hippel-Lindau disease.
Frenzel S; Apel TW; Heidemann PH; Zerres K; Neumann HP; Dörr HG
Eur J Pediatr; 2001 Jul; 160(7):421-4. PubMed ID: 11475579
[TBL] [Abstract][Full Text] [Related]
13. Distinct gene expression profiles in norepinephrine- and epinephrine-producing hereditary and sporadic pheochromocytomas: activation of hypoxia-driven angiogenic pathways in von Hippel-Lindau syndrome.
Eisenhofer G; Huynh TT; Pacak K; Brouwers FM; Walther MM; Linehan WM; Munson PJ; Mannelli M; Goldstein DS; Elkahloun AG
Endocr Relat Cancer; 2004 Dec; 11(4):897-911. PubMed ID: 15613462
[TBL] [Abstract][Full Text] [Related]
14. Differential expression of the regulated catecholamine secretory pathway in different hereditary forms of pheochromocytoma.
Eisenhofer G; Huynh TT; Elkahloun A; Morris JC; Bratslavsky G; Linehan WM; Zhuang Z; Balgley BM; Lee CS; Mannelli M; Lenders JW; Bornstein SR; Pacak K
Am J Physiol Endocrinol Metab; 2008 Nov; 295(5):E1223-33. PubMed ID: 18854424
[TBL] [Abstract][Full Text] [Related]
15. Mutations in the RET proto-oncogene and the von Hippel-Lindau disease tumour suppressor gene in sporadic and syndromic phaeochromocytomas.
Eng C; Crossey PA; Mulligan LM; Healey CS; Houghton C; Prowse A; Chew SL; Dahia PL; O'Riordan JL; Toledo SP
J Med Genet; 1995 Dec; 32(12):934-7. PubMed ID: 8825918
[TBL] [Abstract][Full Text] [Related]
16. [Pheochromocytoma--pathohistologic and immunohistochemical aspects].
Tatić S; Havelka M; Paunović I; Bozić V; Diklic A; Brasanac D; Janković R; Jancić-Zguricas M
Srp Arh Celok Lek; 2002 Jul; 130 Suppl 2():7-13. PubMed ID: 12584991
[TBL] [Abstract][Full Text] [Related]
17. Epigenetic analysis of HIC1, CASP8, FLIP, TSP1, DCR1, DCR2, DR4, DR5, KvDMR1, H19 and preferential 11p15.5 maternal-allele loss in von Hippel-Lindau and sporadic phaeochromocytomas.
Margetts CD; Astuti D; Gentle DC; Cooper WN; Cascon A; Catchpoole D; Robledo M; Neumann HP; Latif F; Maher ER
Endocr Relat Cancer; 2005 Mar; 12(1):161-72. PubMed ID: 15788647
[TBL] [Abstract][Full Text] [Related]
18. [112 cases of sporadic and genetically determined pheochromocytoma: a comparative pathologic study].
Gosset P; Lecomte-Houcke M; Duhamel A; Labat-Moleur F; Patey M; Floquet J; Viennet G; Berger-Dutrieux N; Caillou B; Franc B
Ann Pathol; 1999 Dec; 19(6):480-6. PubMed ID: 10617804
[TBL] [Abstract][Full Text] [Related]
19. Functioning thoracic paraganglioma: association with Von Hippel-Lindau syndrome.
Bender BU; Altehöfer C; Januszewicz A; Gärtner R; Schmidt H; Hoffmann MM; Heidemann PH; Neumann HP
J Clin Endocrinol Metab; 1997 Oct; 82(10):3356-60. PubMed ID: 9329368
[TBL] [Abstract][Full Text] [Related]
20. Bilateral phaeochromocytomas in von Hippel-Lindau disease: diagnosis by adrenal vein sampling and catecholamine assay.
Chew SL; Dacie JE; Reznek RH; Newbould EC; Sheaves R; Trainer PJ; Lowe DG; Shand WS; Hungerford J; Besser GM
Q J Med; 1994 Jan; 87(1):49-54. PubMed ID: 8140217
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
